Expansion of the Management Board of M1 Kliniken AG

EQS-News: M1 Kliniken AG / Key word(s): Personnel
Expansion of the Management Board of M1 Kliniken AG
15.11.2022 / 18:31 CET/CEST
The issuer is solely responsible for the content of this announcement.

Expansion of the Management Board of M1 Kliniken AG

Berlin, 15.11.2022 - At its meeting today, the Supervisory Board of M1 Kliniken AG appointed Mr. Kilian Brenske (28, MBA) to the management board of M1 Kliniken AG.

Mr Brenske has been working for the company for more than six years and during this time has managed and successfully developed all major business areas in Germany and abroad. In particular, he has built up the medical skin care brand M1 Select and most recently significantly improved the productivity of the clinics. Mr. Brenske is therefore excellently prepared for his new tasks as the board member responsible for national and international expansion, marketing and purchasing.

"I am very pleased about the strengthening of the board by Mr. Brenske. Together we will do everything in our power to successfully develop the M1 Med Beauty brand and thus optimally meet the needs of our customers," says Dr. Walter von Horstig, who as the existing board member will in future be responsible for the areas of finance, investor relations, inpatient clinics and administration.

About M1 Kliniken AG

M1 Kliniken AG is the leading provider of beauty medical health services in Germany. In the aesthetic and surgical field, the group of companies offers products and services with the highest quality standards. Under the brand "M1 Med Beauty", beauty medical treatments are currently offered at more than 50 specialist centres. The M1 Schlossklinik for plastic and aesthetic surgery in Berlin, with six operating theatres and 35 beds, is one of the largest and most modern facilities of its kind in Europe. Since the end of 2018, M1 has been pushing ahead with internationalisation and is currently also active in Austria, Switzerland, the Netherlands, England, Croatia, Hungary and Australia. With its stake in HAEMATO AG, M1 Kliniken AG is also in a position to exploit sales and earnings potential of treatment products in the medical-aesthetic field.

15.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com